These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 22065400

  • 1. A randomized, crossover, placebo- and moxifloxacin-controlled study to evaluate the effects of bosutinib (SKI-606), a dual Src/Abl tyrosine kinase inhibitor, on cardiac repolarization in healthy adult subjects.
    Abbas R, Hug BA, Leister C, Sonnichsen D.
    Int J Cancer; 2012 Aug 01; 131(3):E304-11. PubMed ID: 22065400
    [Abstract] [Full Text] [Related]

  • 2. A single-dose, crossover, placebo- and moxifloxacin-controlled study to assess the effects of neratinib (HKI-272) on cardiac repolarization in healthy adult subjects.
    Hug B, Abbas R, Leister C, Burns J, Sonnichsen D.
    Clin Cancer Res; 2010 Aug 01; 16(15):4016-23. PubMed ID: 20647478
    [Abstract] [Full Text] [Related]

  • 3. Ascending single-dose study of the safety profile, tolerability, and pharmacokinetics of bosutinib coadministered with ketoconazole to healthy adult subjects.
    Abbas R, Leister C, El Gaaloul M, Chalon S, Sonnichsen D.
    Clin Ther; 2012 Sep 01; 34(9):2011-9.e1. PubMed ID: 22884766
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Sugammadex is not associated with QT/QTc prolongation: methodology aspects of an intravenous moxifloxacin-controlled thorough QT study.
    de Kam PJ, van Kuijk J, Smeets J, Thomsen T, Peeters P.
    Int J Clin Pharmacol Ther; 2012 Aug 01; 50(8):595-604. PubMed ID: 22735462
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of sugammadex doses up to 32 mg/kg alone or in combination with rocuronium or vecuronium on QTc prolongation: a thorough QTc study.
    de Kam PJ, van Kuijk J, Prohn M, Thomsen T, Peeters P.
    Clin Drug Investig; 2010 Aug 01; 30(9):599-611. PubMed ID: 20568829
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cardiac repolarization with Gabapentin enacarbil in a randomized, double-blind, placebo- and active-controlled, crossover thorough QT/QTc study in healthy adults.
    Davy M, Upward J, Arumugham T, Twomey C, Chen C, Stier B.
    Clin Ther; 2013 Dec 01; 35(12):1964-74. PubMed ID: 24290737
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of a single supratherapeutic dose of dolutegravir on cardiac repolarization.
    Chen S, Min SS, Peppercorn A, Borland J, Lou Y, Song I, Fujiwara T, Piscitelli SC.
    Pharmacotherapy; 2012 Apr 01; 32(4):333-9. PubMed ID: 22422361
    [Abstract] [Full Text] [Related]

  • 15. No effect of a single supratherapeutic dose of lersivirine, a next-generation nonnucleoside reverse transcriptase inhibitor, on corrected QT interval in healthy subjects.
    Vourvahis M, Wang R, Ndongo MN, O'Gorman M, Tawadrous M.
    Antimicrob Agents Chemother; 2012 May 01; 56(5):2408-13. PubMed ID: 22371898
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of a supratherapeutic dose of investigational orally inhaled dihydroergotamine (MAP0004) on QT interval: a randomized, double-blind, active- and placebo-controlled crossover study in healthy volunteers.
    Kori S, Kellerman DJ, Voloshko P, Haugen G.
    Clin Ther; 2012 Sep 01; 34(9):1920-8. PubMed ID: 22917853
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Lack of effect of perampanel on QT interval duration: Results from a thorough QT analysis and pooled partial seizure Phase III clinical trials.
    Yang H, Laurenza A, Williams B, Patten A, Hussein Z, Ferry J.
    Epilepsy Res; 2015 Aug 01; 114():122-30. PubMed ID: 26088895
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.